Will Mounjaro Get Rid of Belly Fat? UK Clinical Evidence Written by Bolt Pharmacy Published on 17/4/2026 Mounjaro (tirzepatide) is a prescription medicine licensed in the UK for type 2 diabetes and weight management in adults with obesity or overweight with weight-related conditions. As a dual GIP/GLP-1 receptor agonist, it reduces appetite and supports substantial […]
Tag Archives: GIP GLP-1 agonist
When to Resume Mounjaro After Surgery: UK Guidance Written by Bolt Pharmacy Published on 22/7/2026 Mounjaro (tirzepatide) is a GLP-1 and GIP receptor agonist used for type 2 diabetes and weight management in the UK. When to resume Mounjaro after surgery depends on the procedure type, recovery progress, and gastrointestinal function. Surgical teams typically advise […]
Green Poop: Causes, When to Worry & What It Means Written by Bolt Pharmacy Published on 5/5/2026 Green stools whilst taking Mounjaro (tirzepatide) can understandably cause concern, but this colour change is typically benign and temporary. Mounjaro, a dual GLP-1 and GIP receptor agonist licensed in the UK for type 2 diabetes mellitus, commonly affects […]
What Colour Is Mounjaro? UK Pen Identification Guide Written by Bolt Pharmacy Published on 17/4/2026 Mounjaro (tirzepatide) is a once-weekly injectable medication licensed in the UK for type 2 diabetes and weight management. The pre-filled pens use a colour-coded system to help identify different dosage strengths—2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, […]
Mounjaro and Skin Tags: Effects, Management and Advice Written by Bolt Pharmacy Published on 10/6/2026 Mounjaro (tirzepatide) is a dual GIP/GLP-1 receptor agonist licensed in the UK for type 2 diabetes and weight management in adults with obesity or overweight with comorbidities. As patients experience substantial weight reduction, many notice various skin changes, including concerns […]
How to Wean Off Mounjaro: Safe Discontinuation Guide Written by Bolt Pharmacy Published on 22/7/2026 Mounjaro (tirzepatide) is a dual GIP and GLP-1 receptor agonist licensed in the UK for type 2 diabetes management. Whilst effective for glycaemic control, various medical, practical, or personal circumstances may necessitate discontinuation. Understanding how to wean off Mounjaro safely […]
Does Mounjaro Cause Blood Clots? Evidence and Safety Profile Written by Bolt Pharmacy Published on 10/6/2026 Mounjaro (tirzepatide) is a dual GIP and GLP-1 receptor agonist licensed in the UK for managing type 2 diabetes mellitus. As with any medication, patients may have concerns about potential side effects, including whether Mounjaro causes blood clots. Understanding […]
Mounjaro and Cortisone Shot: UK Safety Guidance Written by Bolt Pharmacy Published on 14/4/2026 Mounjaro (tirzepatide) is a dual GIP/GLP-1 receptor agonist licensed in the UK for type 2 diabetes management, whilst corticosteroid injections are widely used to treat joint inflammation and musculoskeletal conditions. Patients taking Mounjaro may require steroid injections for conditions such as […]
Does Mounjaro Cause Bleeding? UK Clinical Evidence and Guidance Written by Bolt Pharmacy Published on 15/7/2026 Does Mounjaro cause bleeding? This question concerns many patients prescribed tirzepatide for type 2 diabetes management. Mounjaro (tirzepatide) is a dual GIP and GLP-1 receptor agonist licensed in the UK for treating type 2 diabetes mellitus in adults. Whilst […]
Mounjaro and Alzheimer’s: Current Evidence and What Patients Should Know Written by Bolt Pharmacy Published on 24/7/2026 Mounjaro (tirzepatide) is a dual GIP/GLP-1 receptor agonist licensed in the UK for treating type 2 diabetes mellitus in adults. Emerging research has explored potential links between diabetes medications and Alzheimer’s disease, given that type 2 diabetes increases […]